Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Adherence
E-prescriptions boost adherence data
Deborah Weinstein
May 22, 2012
A new study by Surescripts, the nation's largest e-prescription network, suggests that saving patients the trouble of toting a prescription to a store increases the likelihood that they will get it filled and take their meds.
RX-to-OTC proposal gets mixed reviews
Deborah Weinstein
May 14, 2012
Industry and physician groups expressed wary support for the FDA's "new paradigm" drug proposal, which would create a nonprescription "Behind the Counter" class of drugs available through pharmacists.
Genentech's mind-tapping science moves needle on Pulmozyme, Tamiflu
James Chase
March 28, 2012
Genentech is thinking outside the traditional focus group to understand patients, helping address the long-standing business challenges of adherence and brand preference, the firm says.
Study shows prescription gender gap
Deborah Weinstein
March 21, 2012
Women are simultaneously given more drugs than men and undertreated, according to a study Medco and the Society of Women's Health Research.
Pfizer's Lipitor share slips, casting doubt on power of a loyalty program to save the brand
Matthew Arnold
January 25, 2012
Seven weeks after Pfizer's main Lipitor patent expired in the US, the drug is down to 32% market share and at least one name-brand analyst is casting doubt on the brand's survival strategy.
Merck web widget points to future adherence fix
Matthew Arnold
October 04, 2011
Asking consumers to gauge their risk for non-adherence, Merck is deploying a one-minute survey dubbed the Adherence Estimator that may be the way forward for keeping patients on-treatment.
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
Pharmas are from Mars, Payers are from Venus
Study: Young Latinas are key decision makers, prefer English
Coach vs. cancer in BMS-backed awareness effort
Indian conglomerate buys Manhattan Research parent for $635m
No-see docs are know-nothings when it comes to new drug info, study suggests
How CDC's hep.-C testing advice benefits drugmakers now
National plan seeks Alzheimer's treatment by 2025
Study: Young Latinas are key decision makers, prefer English
Wolters Kluwer deals health analytics unit to private equity firm
Pharmas are from Mars, Payers are from Venus
Indian conglomerate buys Manhattan Research parent for $635m
No-see docs are know-nothings when it comes to new drug info, study suggests
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Coach vs. cancer in BMS-backed awareness effort
National plan seeks Alzheimer's treatment by 2025
E-prescriptions boost adherence data
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Popular Topics
Acquisition
Adherence
Agency
App
Celebrity
Clinical Trial
Co-Marketing
Conflict Of Interest
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Sales Force